What an excellent, considered synopsis @Half Full
The fact that the head of Detroit Childrens pulmonary Dept (Associate Professor Pavadee Poowuttikul, Division Chief of Allergy/Immunology and Rheumatology) has put her reputation on the line also speaks volumes. The US are nearly always the pioneers in implementing new technologies and it’s clear they see the utility in wheezo. Can’t wait for the update this Friday at 11am to hear about progress in the US. I’m sure those serious in finding out answers can submit their questions to the company as volunteered by the company.
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial, page-29
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.80M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400000 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 199999 | 1 |
View Market Depth
| Last trade - 16.12pm 04/07/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable